CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $37,943
- in 1 filing
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,584,591. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +2,400 | $3.60 | $9K | 38,800 |
| 2024-11-25 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +10,000 | $3.88 | $39K | 48,800 |
| 2024-11-25 | Spoor Johan M. CEO | Purchase | +14,500 | $3.78 | $55K | 152,072 |
| 2024-11-25 | Spoor Johan M. CEO | Purchase | +5,400 | $3.80 | $21K | 5,400 |
| 2024-11-25 | Spoor Johan M. CEO | Purchase | +6,600 | $3.80 | $25K | 66,600 |
| 2024-07-17 | Austin Mark John VP Finance/Prin Fin&Acct Offic | Grant or award · Stock Option (right to buy) | +34,500 | 34,500 | ||
| 2024-06-20 | Williamson Robert F III Director | Grant or award · Stock option (right to buy) | +23,000 | 23,000 | ||
| 2024-06-20 | Morich Frank Director | Grant or award · Stock option (right to buy) | +23,000 | 23,000 | ||
| 2024-06-20 | Woods Lori A Director | Grant or award · Stock option (right to buy) | +23,000 | 23,000 | ||
| 2024-06-20 | HENSON HEIDI Director | Grant or award · Stock option (right to buy) | +23,000 | 23,000 | ||
| 2024-06-20 | Spoor Johan M. CEO | Grant or award · Stock option (right to buy) | +500,000 | 500,000 | ||
| 2024-06-20 | Puhlmann Markus Chief Medical Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2024-06-20 | Hunt Jonathan Robert Chief Financial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2024-06-17 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +1,800 | $9.82 | $18K | 35,971 |
| 2024-06-14 | Woods Lori A Director | Purchase | +4,504 | $10.90 | $49K | 159,902 |
| 2024-06-14 | Woods Lori A Director | Purchase | +83 | $10.80 | $896 | 159,985 |
| 2024-06-13 | Spoor Johan M. CEO | Purchase | +100,000 | $1.17 | $117K | 137,572 |
| 2024-06-03 | Woods Lori A Director | Purchase | +34,246 | $1.46 | $50K | 1,553,984 |
| 2024-05-31 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +13,006 | $1.40 | $18K | 329,716 |
| 2024-05-31 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +12,000 | $1.40 | $17K | 341,716 |
Page 3 of 26 · 502 trades